CIEN participates in the 11th National and 15th Ibero-American Alzheimer Congresses organized by CEAFA

CIEN has played an active role in the 11th National Alzheimer Congress and the 15th Ibero-American Alzheimer Congress, held from November 5 to 8 at the Ibiza Exhibition Center under the presidency of Her Majesty Queen Sofía of Spain.

Under the theme “Breaking Borders,” the event—organized by the Spanish Confederation of Alzheimer’s (CEAFA) and the Ibero-American Alzheimer’s Association (AIB)—brought together more than 500 professionals, family caregivers, volunteers, and researchers from various countries. The congress has once again become a key meeting point for exchanging knowledge and experiences on dementia.

CIEN participation

CIEN’s contribution to this year’s congress stood out through the participation of its team members in several scientific sessions:

• María Ángeles Pérez Muñoz, Managing Director of CIEN, took part yesterday, November 7, in CEAFA’s Research Panel, focused on “Biomedical, Social, and Health Research.” In her talk, she highlighted the importance of research as a driving force for improving care and quality of life for people affected by Alzheimer’s disease and other dementias.
• Dr. Pascual Sánchez-Juan, Scientific Director of CIEN, also participated on November 7 in the session “How Alzheimer’s Affects the Caregiver,” addressing the cognitive, emotional, and social impacts of caregiving.

Today, November 8, he took part in the session “New Drugs for Alzheimer’s Disease,” where he discussed the latest advances in therapeutic research and the development of new treatments currently emerging at the international level.

A space for science, awareness, and collaboration

Promoted by CEAFA and AIB, the Congress featured representatives from major international organizations such as Alzheimer Europe and Alzheimer’s Disease International (ADI), strengthening cooperation among scientific institutions, associations, and professionals from the social and healthcare sectors.

For CIEN, which operates under the Carlos III Health Institute (Ministry of Science, Innovation, and Universities), this participation reaffirms the institution’s commitment to scientific research, social awareness, and evidence-based policy development aimed at improving the lives of people with dementia and their families.